Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
Weigl
Daniel M
DM
Arbel
Nili
N
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002675:Child, Preschool; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D028761:Withholding Treatment
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A